Tumors begin to shrink
What followed was a period of trial and error. Zofia began chemotherapy, but progress was slow at first. For nine months, scans showed little improvement. She asked a heartbreaking question of her mother: “Why do I have to do this?”
Then, finally, there was movement in the right direction. The tumors began to shrink. Today, PET scans show about 15 percent of disease remaining.
Treatment to protect her bones
Along the way, treatment brought new challenges. Zofia developed dangerously low calcium and phosphorus levels from zoledronate therapy (a medication used for certain bone tumors and bone fragility). Her blood mineral levels were managed by endocrinologist Nancy Dunbar, MD, Director of the Bone and Mineral Disorders Program.
Orthopedic oncologist Adam Lindsay, MD, inserted a rod in her femur to prevent the bone from breaking. The rod can be removed when her cancer treatment ends. She used crutches to get around and needed a stroller during a special trip to see Taylor Swift in concert.
Powering through months of chemotherapy and radiation
Today, Zofia is nine years old and still receiving treatment—oral chemotherapy and radiation sessions five days a week. Infusion chemotherapy will resume after she completes her radiation treatments. She is closely monitored by a multidisciplinary team at Connecticut Children’s that includes orthopedics, cardiology, endocrinology, physical therapy, and psychology.